Literature DB >> 2693729

Antimalarial drugs currently in development.

W E Gutteridge1.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2693729      PMCID： PMC1291944     

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  12 in total

1.  Introduction of halofantrine for malaria treatment.

Authors:  R J Horton
Journal:  Parasitol Today       Date:  1988-09

2.  Prophylactic treatment of vivax and falciparum malaria with low-dose doxycycline.

Authors:  L Pang; N Limsomwong; P Singharaj
Journal:  J Infect Dis       Date:  1988-11       Impact factor: 5.226

3.  [Effects of artesunate, pyronaridine and hydroxypiperaquine on chloroquine-sensitive and chloroquine-resistant isolates of Plasmodium falciparum in vitro].

Authors:  J Li; W J Huang
Journal:  Zhongguo Yao Li Xue Bao       Date:  1988-01

4.  In vitro and in vivo studies of the effects of halogenated histidine analogs on Plasmodium falciparum.

Authors:  L J Panton; R N Rossan; A Escajadillo; Y Matsumoto; A T Lee; V M Labroo; K L Kirk; L A Cohen; M Aikawa; R J Howard
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

Review 5.  The multidrug transporter, a double-edged sword.

Authors:  M M Gottesman; I Pastan
Journal:  J Biol Chem       Date:  1988-09-05       Impact factor: 5.157

6.  Quinolones and multiresistant Plasmodium falciparum.

Authors:  J M Midgley; D W Keter; J D Phillipson; S Grant; D C Warhurst
Journal:  Lancet       Date:  1988-07-30       Impact factor: 79.321

7.  In vitro activity of natural and synthetic naphthoquinones against erythrocytic stages of Plasmodium falciparum.

Authors:  L H Carvalho; E M Rocha; D S Raslan; A B Oliveira; A U Krettli
Journal:  Braz J Med Biol Res       Date:  1988       Impact factor: 2.590

8.  The in vitro and in vivo antimalarial activity of some Mannich bases derived from 4-[7'-bromo (and chloro)-1',5'-naphthyridin-4'-ylamino]phenol and 4-(7'-trifluoromethylquinolin-4'-ylamino)phenol.

Authors:  H V Scott; W L Tan; G B Barlin
Journal:  Ann Trop Med Parasitol       Date:  1988-04

9.  Reversal of chloroquine resistance in Plasmodium falciparum by verapamil.

Authors:  S K Martin; A M Oduola; W K Milhous
Journal:  Science       Date:  1987-02-20       Impact factor: 47.728

10.  Glutathione reductase inhibitors as potential antimalarial drugs. Effects of nitrosoureas on Plasmodium falciparum in vitro.

Authors:  Y A Zhang; E Hempelmann; R H Schirmer
Journal:  Biochem Pharmacol       Date:  1988-03-01       Impact factor: 5.858
View more
  6 in total

1.  Approval of Tafenoquine for Malaria Chemoprophylaxis.

Authors:  Jonathan D Berman
Journal:  Am J Trop Med Hyg       Date:  2019-06       Impact factor: 2.345

Review 2.  Tafenoquine and G6PD: a primer for clinicians.

Authors:  Cindy S Chu; David O Freedman
Journal:  J Travel Med       Date:  2019-06-01       Impact factor: 8.490

Review 3.  Artemisia annua L.: a source of novel antimalarial drugs.

Authors:  H J Woerdenbag; C B Lugt; N Pras
Journal:  Pharm Weekbl Sci       Date:  1990-10-19

4.  Parameters determining the relative efficacy of hydroxy-naphthoquinone inhibitors of the cytochrome bc1 complex.

Authors:  Jacques J Kessl; Nikolai V Moskalev; Gordon W Gribble; Mohamed Nasr; Steven R Meshnick; Bernard L Trumpower
Journal:  Biochim Biophys Acta       Date:  2007-02-27

5.  Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii.

Authors:  F G Araujo; J Huskinson; J S Remington
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

6.  Tafenoquine for travelers' malaria: evidence, rationale and recommendations.

Authors:  J Kevin Baird
Journal:  J Travel Med       Date:  2018-01-01       Impact factor: 8.490
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.